EXCLUSIVE — Nearly 50 House Republicans are investigating efforts by the Biden-Harris administration to keep insurance premiums for Medicare prescription coverage low, which Republicans say is an illegitimate attempt to limit the fallout from the president’s drug-pricing policies in the 2024 campaign cycle.

Rep. Brett Guthrie (R-KY), the chairman of the Energy and Commerce Subcommittee on Health, told the Washington Examiner in an exclusive interview that Medicare Part D prescription drug premiums have dramatically increased since the passage of the Inflation Reduction Act in 2022, which was intended to lower healthcare costs for seniors. 

Recommended Stories

Election year Medicare move costs taxpayers $21B over next 3 years

Guthrie will use key panel to roll back Biden Medicare changes and oversee agencies

Medicare Advantage rates to drop slightly